Description
| Item ID # | 24318900 |
| Manufacturer # | 2431161 |
| Brand | |
Features
- 2 pouches of 30 bulk wrapped vials
Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 60 Vials
UOM CARTON/60
$11.95
Features
- 2 pouches of 30 bulk wrapped vials
9999 in stock
Related products
-
#58198900 Mfr#Fluarix® Quadrivalent Flu Vaccine 60 mcg / 0.5 mL Users 3 Years and Older Prefilled Syringe 0.5 mL
Features
- FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
- FLUARIX QUADRIVALENT is approved for use in persons 3 years of age and older
-
#40988900 Mfr# 1107424Nitrostat® Nitrate Nitroglycerin 0.4 mg Sublingual Tablet Bottle 25 Tablets
Features
- NITROSTAT is a stabilized sublingual compressed nitroglycerin tablet
- The principal pharmacological action of nitroglycerin is relaxation of vascular smooth muscle
- Although venous effects predominate, nitroglycerin produces, in a dose-related manner, dilation of both arterial and venous beds
-
#14698900 Mfr#Pulmicort Respules® Orally Inhaled Steroid Budesonide 1 mg / 2 mL Unit Dose, Inhalation Suspension Nebulizer Ampule 30 Ampules
Features
- PULMICORT RESPULES is supplied in sealed aluminum foil envelopes containing one plastic strip of five single-dose RESPULES ampules together with patient instructions for use
- Each single-dose RESPULES ampule contains 2 mL of sterile liquid suspension
- PULMICORT RESPULES should be stored upright at controlled room temperature 20 – 25 degrees celsius (68 – 77 degrees fahrenheit), and protected from light
-
#58908900 Mfr#Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart